Current Value of Holding

$5.24 Billion

Shares

44.7 Million

% of Portfolio

4.12%

Average Buy Price

$127

Avg closing price
Price range

22 Baillie Gifford Moderna Trades

Baillie Gifford's position in Moderna is currently worth $5.24 Billion. That's 4.12% of their equity portfolio (5th largest holding). The investor owns 11.14% of the outstanding Moderna stock. The first Moderna trade was made in Q4 2018. Since then Baillie Gifford bought shares thirteen more times and sold shares on eight occasions. The investor's estimated purchase price is $5.68 Billion, resulting in a loss of 7.8%.

Avg closing price
Price range
Sold 2.2% shares (-999 Thousand shares) Q1 2024
Avg closing price $100.80
Price range $85.37 - $115.44
Increased shares by 0.0% (+5.34 Thousand shares) Q4 2023
Avg closing price $84.11
Price range $69.51 - $104.43
Sold 0.1% shares (-61.9 Thousand shares) Q3 2023
Avg closing price $111.55
Price range $96.41 - $126.61
Sold 1.6% shares (-755 Thousand shares) Q2 2023
Avg closing price $133.40
Price range $118.50 - $160.53
Increased shares by 3.7% (+1.68 Million shares) Q1 2023
Avg closing price $164.97
Price range $135.66 - $197.02
Sold 1.1% shares (-493 Thousand shares) Q4 2022
Avg closing price $163.51
Price range $118.38 - $210.04
Sold 0.6% shares (-280 Thousand shares) Q3 2022
Avg closing price $151.74
Price range $118.07 - $194.18
Sold 0.2% shares (-69.4 Thousand shares) Q2 2022
Avg closing price $142.94
Price range $117.13 - $176.59
Sold 0.3% shares (-143 Thousand shares) Q1 2022
Avg closing price $168.36
Price range $126.46 - $235.05
Increased shares by 8.4% (+3.55 Million shares) Q4 2021
Avg closing price $292.38
Price range $225.82 - $368.51
Sold 8.0% shares (-3.67 Million shares) Q3 2021
Avg closing price $368.80
Price range $221.90 - $484.47
Increased shares by 1.2% (+545 Thousand shares) Q2 2021
Avg closing price $178.71
Price range $129.91 - $234.98
Increased shares by 86.5% (+21 Million shares) Q1 2021
Avg closing price $144.91
Price range $109.18 - $185.98
Increased shares by 236.5% (+17.1 Million shares) Q4 2020
Avg closing price $101.17
Price range $65.74 - $169.86
Increased shares by 78.0% (+3.17 Million shares) Q3 2020
Avg closing price $69.72
Price range $54.34 - $94.85
Increased shares by 14.0% (+500 Thousand shares) Q2 2020
Avg closing price $54.76
Price range $29.67 - $80.00
Increased shares by 4.2% (+144 Thousand shares) Q1 2020
Avg closing price $23.01
Price range $17.78 - $31.58
Increased shares by 6.3% (+201 Thousand shares) Q4 2019
Avg closing price $17.74
Price range $13.93 - $21.28
Increased shares by 0.2% (+7.2 Thousand shares) Q3 2019
Avg closing price $14.77
Price range $12.26 - $18.07
Increased shares by 24.6% (+632 Thousand shares) Q2 2019
Avg closing price $21.48
Price range $13.70 - $28.34

News about Moderna Inc and Baillie Gifford

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!